Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease

被引：3
|
作者：
Nunez-Gomez, Laura [1 ]
Mesonero-Gismero, Francisco [1 ]
Albillos-Martinez, Agustin [1 ]
Lopez-Sanroman, Antonio [1 ]
机构：
[1] Hosp Univ Ramon y Cajal, Serv Gastroenterol & Hepatol, Madrid, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2018年 / 41卷 / 09期
关键词：
Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Anti-TNF; EVIDENCE-BASED CONSENSUS; INFLAMMATORY-BOWEL-DISEASE; ANTI-TNF THERAPY; EXTRAINTESTINAL MANIFESTATIONS; CLINICAL CHARACTERISTICS; PYODERMA-GANGRENOSUM; FACTOR ANTAGONISTS; NATURAL-HISTORY; INFLIXIMAB; FISTULAS;
D O I：
10.1016/j.gastrohep.2018.06.010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Anti-tumor necrosis factor agents (anti-TNF) drugs are commonly used in patients with inflammatory bowel disease (IBD) and have proven effective in both induction and maintenance therapy in luminal Crohn's disease and ulcerative colitis. Their efficacy has also been proven in fistulising perianal Crohn's disease. However, the evidence in other scenarios, such as stricturing, penetrating and non-fistulising perianal Crohn's disease, extraintestinal IBD manifestations and ileoanal reservoir complications, is not as robust. The aim of this review was to perform an analysis of the available literature and to determine the rote of anti-TNF drugs in common clinical practice in patients affected by these complications. (C) 2018 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：576 / 582
页数：7
相关论文
共 50 条
  • [1] Update on Anti-Tumor Necrosis Factor Agents in Crohn Disease
    Singh, Siddharth
    Pardi, Darrell S.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 457 - +
  • [2] Mechanisms of Action of Anti-tumor Necrosis Factor a Agents in Crohn's Disease
    Peake, Simon T. C.
    Bernardo, David
    Mann, Elizabeth R.
    Al-Hassi, Hafid O.
    Knight, Stella C.
    Hart, Ailsa L.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1546 - 1555
  • [3] Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?
    Pouillon, Lieven
    Van Stappen, Johan
    Bossuyt, Peter
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2018, 32-33 : 17 - 25
  • [4] A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease
    Papamichael, Konstantinos
    Mantzaris, Gerassimos J.
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 493 - 501
  • [5] Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn's disease
    Nguyen, Douglas L.
    Flores, Sarah
    Sassi, Kareem
    Bechtold, Matthew L.
    Nguyen, Emily T.
    Parekh, Nimisha K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (03) : 147 - 154
  • [6] Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis
    Kevans, David
    Waterman, Matti
    Milgrom, Raquel
    Xu, Wei
    Van Assche, Gert
    Silverberg, Mark
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 64 - 70
  • [7] Tacrolimus Salvage in Anti-Tumor Necrosis Factor Antibody Treatment-Refractory Crohn's Disease
    Gerich, Mark E.
    Pardi, Darrell S.
    Bruining, David H.
    Kammer, Patricia P.
    Becker, Brenda D.
    Tremaine, William T.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1107 - 1111
  • [8] The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn's Disease: a Systematic Review
    El-Hussuna, Alaa
    Krag, Aleksander
    Olaison, Gunnar
    Bendtsen, Flemming
    Gluud, Lise L.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1423 - 1433
  • [9] Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease
    Netz, Uri
    Carter, Jane Victoria
    Eichenberger, Maurice Robert
    Dryden, Gerald Wayne
    Pan, Jianmin
    Rai, Shesh Nath
    Galandiuk, Susan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (27) : 4958 - 4967
  • [10] Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease
    Weizman, Adam V.
    Sharma, Robyn
    Afzal, N. M.
    Xu, Wei
    Walsh, Scott
    Stempak, Joanne M.
    Nguyen, Geoffrey C.
    Croitoru, Ken
    Steinhart, A. Hillary
    Silverberg, Mark S.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (09) : 2430 - 2438
12345